Europe and Israel mobile applications for melanoma detection market is estimated to be valued at US$ 1.1 million in 2021 and is expected to exhibit a CAGR of 19.6 % over the forecast period (2021-2028).
Figure 1. Europe and Israel Mobile Applications for Melanoma Detection Market Value (US$ Mn), by Region, 2020
Market Trends
Development of new technologies is expected to propel growth of the Europe and Israel mobile applications for melanoma detection market. For instance, in December 2019, Denmark-based company Miiskin reported development of AI-powered skin mapping technology to detect early warning signs of melanoma.
The market in Europe is witnessing approval and launch of new therapies. For instance, in May 2020, OncoSec Medical Inc., a company developing late-stage intratumoral cancer immunotherapies, received the European Medicines Agency’s advanced therapy medicinal product certificate for chemistry manufacturing controls data covering its lead product candidate, TAVO (interleukin-12 or "IL-12" plasmid), for the treatment of metastatic melanoma.
Figure 2. Global Europe and Israel Mobile Applications for Melanoma Detection Market Share, By Type, 2020
Key Takeaways of the Graph:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients